Tags: cancermetforminmyeloid leukemiaburn scarsmarjolin's ulcer
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Advances in Cancer Therapies and Diagnostics - 25 days ago New Research Avenues Provide Hope for Metastatic Disease - 10 months ago Tapping Into Immunotherapy’s Potential to Help More People - 11 months ago | |
2 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | Biopharma leaders lay out vision for the future of blood cancer treatment - about 2 months ago | |
4 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | Biopharma leaders lay out vision for the future of blood cancer treatment - about 2 months ago The latest updates on cancer research from the weekend - 10 months ago | |
5 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | Biopharma leaders lay out vision for the future of blood cancer treatment - about 2 months ago STAT+: Can iTeos and GSK solve TIGIT’s troubles? - 5 months ago | |
6 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | Biopharma leaders lay out vision for the future of blood cancer treatment - about 2 months ago | |
7 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
8 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 5 months ago | |
9 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
10 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California |